Abstract
Introduction
Transmission of hepatitis E virus (HEV) through transfusion has been reported from countries where genotype 3 virus is predominant. Data from countries with predominantly genotype 1 HEV, such as India, are limited. We studied the risk of HEV transmission following transfusion of blood or blood components in India.
Methods
Adult patients undergoing cardiac surgery who received transfusion of blood or blood products in the peri-operative period and who lacked history of any transfusion or surgery in the preceding 1 year were studied. A pre-transfusion blood specimen was collected for IgG anti-HEV antibody test. For the participants who were seronegative for anti-HEV, follow up specimens were collected at every 2–3-month intervals for up to 6 months after surgery and were tested for IgM and IgG anti-HEV antibodies.
Results
Of the 335 participants originally enrolled, 191 (57%) could be followed up. Of them, 103 (53.9%) were seropositive for HEV IgG at baseline and were excluded. Of the remaining 88 participants (age 42 ± 14.1 years; 55 [63%] male), none reported hepatitis-like illness during the follow up period of 81 ± 23 days. Also, none of these 88 participants was found to have seroconversion to anti-HEV IgM or IgG positivity in the follow up specimens.
Conclusion
Transfusion-mediated transmission of HEV was not observed in our cohort and may be infrequent in the Indian population, where genotype 1 is the predominant HEV type.
Similar content being viewed by others
References
Aggarwal R, Goel A. Advances in hepatitis E - I: virology, pathogenesis and diagnosis. Expert Rev Gastroenterol Hepatol. 2016;10:1053–63.
Belabbes EH, Bouguermouh A, Benatallah A, Illoul G. Epidemic non-A, non-B viral hepatitis in Algeria: strong evidence for its spreading by water. J Med Virol. 1985;16:257–63.
Khuroo MS. Hepatitis E: the enterically transmitted non-A, non-B hepatitis. Indian J Gastroenterol. 1991;10:96–100.
Kamar N, Pischke S. Acute and persistent hepatitis E virus genotype 3 and 4 infection: clinical features, pathogenesis, and treatment. Cold Spring Harbor Perspect Med. 2019;9:a031872.
Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 2004;44:934–40.
Boxall E, Herborn A, Kochethu G, et al. Transfusion-transmitted hepatitis E in a ‘nonhyperendemic’ country. Transfus Med. 2006;16:79–83.
Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384:1766–73.
Petrik J, Lozano M, Seed CR, et al. Hepatitis E. Vox Sang. 2016;110:93–103.
Aggarwal R, Goel A. Screening transfusions for hepatitis E virus: is it needed in India? Natl Med J India. 2015;28:217–9.
Aggarwal R. The global prevalence of hepatitis E virus infection and susceptibility: a systematic review. Geneva: World Health Organization; 2010. http://whqlibdoc.who.int/hq/2010/WHO_IVB_10.14_eng.pdf. Accessed 1 Mar 2020.
Al-Sadeq DW, Majdalawieh AF, Nasrallah GK. Seroprevalence and incidence of hepatitis E virus among blood donors: a review. Rev Med Virol. 2017:e1937.
National AIDS Control Organization, New Delhi. National estimation of blood requirement in India. 2018: New Delhi. Available at: http://naco.gov.in/sites/default/files/Final/Estimation/Report/of/Blood/Requirement/in/India/281/29.pdf. Accessed 14 Nov 2019.
Fujiwara S, Yokokawa Y, Morino K, et al. Chronic hepatitis E: a review of the literature. J Viral Hepat. 2014;21:78–89.
Arankalle VA, Chobe LP. Hepatitis E virus: can it be transmitted parenterally? J Viral Hepat. 1999;6:161–4.
Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol. 2004;19:778–84.
Katiyar H, Goel A, Sonker A, et al. Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India. Indian J Gastroenterol. 2018;37:342–6.
Funding
This work was supported by an intramural research grant from the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, to AG. HK was supported by a grant from the Department of Biotechnology, Government of India.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
VJH, AG, HK, SKA, SP, and RA declare that they have no conflict of interest.
Ethics statement
The study was performed conforming to the Helsinki declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com. The study was approved by our institution’s Ethics Committee, and each participant provided a written informed consent.
Disclaimer
The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, or the printer/publishers are responsible for the results/findings and content of this article.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Halkurike, V.J., Goel, A., Katiyar, H. et al. Blood transfusion is unlikely to be a source for hepatitis E virus transmission in India. Indian J Gastroenterol 39, 161–164 (2020). https://doi.org/10.1007/s12664-020-01033-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-020-01033-y